Zip Water invented the HydroTap Touch-Free Wave earlier this year to meet shifting global customer demand brought about by the COVID-19 pandemic. [ + ]

Older Australians may be missing out on protection against pertussis because GPs tend to focus on vaccinating those in close contact with young children. [ + ]

Which prescription medicines are most commonly used in Australia? Which have the greatest cost to the Australian Government? [ + ]

Pfizer and BioNTech may face major hurdles in getting their vaccine to market, despite recently being touted as winners of the COVID-19 vaccine race. [ + ]

QIMR Berghofer Medical Research Institute is calling for south-east Queenslanders diagnosed with obsessive-compulsive disorder to join a clinical trial of a new brain stimulation treatment. [ + ]

Marking World AIDS Day on 1 December, HIV advocates are calling for greater efforts and coordination to eliminate HIV-related stigma. [ + ]

AMSL Aero and aeromedical organisation CareFlight have launched Vertiia — an efficient electric air ambulance built to tackle rural and regional healthcare inequality and save more lives. [ + ]

Eight organisations and teams have been recognised across disability services, allied health, aged care and community services in a virtual celebration of excellence. [ + ]

The HS8 platform is specifically designed for hospitals, enabling paperless controlled drug administration in all areas of a hospital. [ + ]

Whiteley Corporation has taken out two Hunter Business Awards, acknowledging the hard work and dedication Whiteley has provided to its customers and suppliers during the pandemic. [ + ]

The Society of Hospital Pharmacists of Australia (SHPA) has hosted a successful, celebratory and all-virtual 2020 SHPA Virtual Congress. [ + ]

The innovative project will integrate genomics, electronic healthcare data and AI technologies to address antimicrobial resistance in the healthcare system. [ + ]

A tech partnership means that carers can now access a tool to help identify, monitor and reduce pain in dementia aged-care residents. [ + ]

Interim analysis of Moderna's Phase 3 study of mRNA-1273 finds that the COVID-19 vaccine candidate has an efficacy of 94.5% and remains stable at -20°C for up to six months. [ + ]

BD will deliver millions of disposable needles, syringes and sharps collectors over the next 12 months, to support Australia's COVID-19 Vaccine and Treatment Strategy. [ + ]